Breakthrough of glycobiology in the 21st century

被引：7
|
作者：
Mahara, Gehendra [1 ,2 ]
Tian, Cuihong [1 ,2 ,3 ]
Xu, Xiaojia [1 ,3 ,4 ]
Zhu, Jinxiu [5 ,6 ]
机构：
[1] First Affiliated Hosp Shantou Univ Med Coll, Clin Res Ctr, Shantou, Guangdong, Peoples R China
[2] First Affiliated Hosp Shantou Univ Med Coll, Dept Cardiovasc Med, Shantou, Guangdong, Peoples R China
[3] Edith Cowan Univ, Ctr Precis Hlth, Perth, WA, Australia
[4] First Affiliated Hosp Shantou Univ Med Coll, Dept Infect Control, Shantou, Guangdong, Peoples R China
[5] First Affiliated Hosp Shantou Univ Med Coll, Inst Clin Electrocardiog, Shantou, Guangdong, Peoples R China
[6] Shantou Univ Med Coll, Longgang Matern & Child Inst, Shenzhen, Guangdong, Peoples R China
来源：
FRONTIERS IN IMMUNOLOGY | 2023年 / 13卷
基金：
中国国家自然科学基金;
关键词：
glycobiology; glycan; carbohydrate; nanotechnology; drug development; vaccine; GLYCOSYLATION; GLYCANS; GLYCOPROTEOMICS; GLYCOMICS;
D O I：
10.3389/fimmu.2022.1071360
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
As modern medicine began to emerge at the turn of the 20th century, glycan-based therapies advanced. DNA- and protein-centered therapies became widely available. The research and development of structurally defined carbohydrates have led to new tools and methods that have sparked interest in the therapeutic applications of glycans. One of the latest omics disciplines to emerge in the contemporary post-genomics age is glycomics. In addition, to providing hope for patients and people with different health conditions through a deeper understanding of the mechanisms of common complex diseases, this new specialty in system sciences has much to offer to communities involved in the development of diagnostics and therapeutics in medicine and life sciences.This review focuses on recent developments that have pushed glycan-based therapies into the spotlight in medicine and the technologies powering these initiatives, which we can take as the most significant success of the 21st century.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Challenges facing vaccinators in the 21st century: results from a focus group qualitative study
    Wiot, Frederique
    Shirley, Jane
    Prugnola, Anna
    Di Pasquale, Alberta
    Philip, Roy
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (12) : 2806 - 2815
  • [42] SARS-CoV-2 vaccines - the biggest medical research project of the 21st century
    Kurup, Drishya
    Schnell, Matthias J.
    CURRENT OPINION IN VIROLOGY, 2021, 49 : 52 - 57
  • [43] Drug Delivery Interfaces in the 21st Century: From Science Fiction Ideas to Viable Technologies
    Chertok, Beata
    Webber, Matthew J.
    Succi, Marc D.
    Langer, Robert
    MOLECULAR PHARMACEUTICS, 2013, 10 (10) : 3531 - 3543
  • [44] Ligand Binding Assays in the 21st Century Laboratory: Recommendations for Characterization and Supply of Critical Reagents
    O'Hara, Denise M.
    Theobald, Valerie
    Egan, Adrienne Clements
    Usansky, Joel
    Krishna, Murli
    TerWee, Julie
    Maia, Mauricio
    Spriggs, Frank P.
    Kenney, John
    Safavi, Afshin
    Keefe, Jeannine
    AAPS JOURNAL, 2012, 14 (02): : 316 - 328
  • [45] Past, present, and future of Phase 3 vaccine trial design: rethinking statistics for the 21st century
    Janani, Leila
    Phillips, Rachel
    Van Vogt, Ellie
    Liu, Xinxue
    Waddington, Claire
    Cro, Suzie
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2024, 219 (01)
  • [46] Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities
    Pistollato, Francesca
    Ohayon, Elan L.
    Lam, Ann
    Langley, Gillian R.
    Novak, Thomas J.
    Pamies, David
    Perry, George
    Trushina, Eugenia
    Williams, Robin S. B.
    Roher, Alex E.
    Hartung, Thomas
    Harnad, Stevan
    Barnard, Neal
    Morris, Martha Clare
    Lai, Mei-Chun
    Merkley, Ryan
    Chandrasekera, P. Charukeshi
    ONCOTARGET, 2016, 7 (26) : 38999 - 39016
  • [47] A novel H1N1 virus causes the first pandemic of the 21st century
    Peiris, J. S. Malik
    Tu, Wen-wei
    Yen, Hui-ling
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (11) : 2946 - 2954
  • [48] Review Article: Plague Gives Surprises in the First Decade of the 21st Century in the United States and Worldwide
    Butler, Thomas
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2013, 89 (04) : 788 - 793
  • [49] Teixobactins: a new class of 21st century antibiotics to combat multidrug-resistant bacterial pathogens
    Iyer, Abhishek
    Madder, Annemieke
    Singh, Ishwar
    FUTURE MICROBIOLOGY, 2019, 14 (06) : 457 - 460
  • [50] Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization
    van den Biggelaar, Anita H. J.
    Poolman, Jan T.
    EXPERT REVIEW OF VACCINES, 2016, 15 (01) : 69 - 80
12345